Pulmonary Hypertension

 

  • Christopher King, MD received consulting fees from United Therapeutics, Merck, and Altavant. All relevant financial relationships listed here have been mitigated.
Session date: 
06/28/2023 - 7:30am to 8:30am EDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
Please login or register to take this course.